PhaseBio Pharmaceuticals, Inc. (PHAS)

Cash & Short-Term Investments

$7.80M

Quarterly · Period ending: · USD

PHAS logo

PHAS Cash & Short-Term Investments

Latest reported$41.80M
PHAS FY Cash & Short-Term Investments ($3.72M → $41.80M)
High-resolution chart · PNG

PHAS cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
41,800,000
28,122,000
74,025,000
61,031,000
13,406,000
3,715,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.